Design and interim safety analysis of GeparX trial

International cancer control plans

Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma

Avelumab in combinations for lung cancer and update from ALEX study

Updates in melanoma from ASCO 2018

Novel fusion proteins to target PD-L1 in HPV associated cancers

Phase I study results of M7824 for patients with HPV associated cancers

Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancer

Pancreatic survival improved with trial chemotherapy regimen after surgery

Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen

Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals

Pancreatic cancer survival extended by over a year with chemotherapy regimen